Citius Oncology (CTOR) Interest Coverage Ratio (2023 - 2026)

Citius Oncology (CTOR) has 4 years of Interest Coverage Ratio data on file, last reported at 4.16 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 98.31% year-over-year to 4.16 in Q1 2026; TTM through Mar 2026 was 6.32, a 95.2% increase from a year earlier, with the FY2025 full-year figure at 4.37, down 149.14% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 4.16, down from 0.16 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for CTOR reached as high as 0.11 in Q2 2025 and fell as low as 246.03 in Q1 2025.
• Historically, Interest Coverage Ratio has averaged 61.78 across 4 years, with a median of 9.01 in 2024.
• On a YoY basis, Interest Coverage Ratio climbed as much as 99.93% in 2025 and fell as far as 5466.6% in 2025.
• Year by year, Interest Coverage Ratio stood at 149.93 in 2023, then surged by 90.92% to 13.61 in 2024, then jumped by 98.84% to 0.16 in 2025, then sank by 2533.13% to 4.16 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 4.16 in Q1 2026, 0.16 in Q4 2025, and 46.58 in Q3 2025.